新英格兰地区择期EVAR术后主要不良事件率的比较:一种新的并发症严重程度指标
研究分析新英格兰血管研究组30个中心2003-2016年4731例择期EVAR患者,发现各中心观察MAE率差异大(0%-39%),预测MAE率变异小(21%-29%),且观察MAE率与并发症严重指数呈负相关,提示MAE率可能不是评估择期EVAR结局的良好指标。
要点
- 择期EVAR后各中心观察MAE率差异大,范围0%-39%。
- 高MAE率中心并发症严重程度反而较低,两者呈负相关。
- MAE率可能不足以单独作为择期EVAR的质量评估指标。
核心结论
- 择期EVAR后MAE率在不同中心间差异很大,但MAE率较高的中心并发症严重程度较低,提示观察MAE率可能不是评估择期EVAR结局的良好指标。
研究设计与样本
- 回顾性队列研究,纳入新英格兰血管研究组30个中心2003-2016年择期EVAR患者4731例。
- MAE复合终点包括心肌梗死、心律失常、充血性心力衰竭、下肢缺血、肾功能不全、肠道并发症、再手术、手术部位感染、卒中、呼吸系统并发症及非家庭出院。
- 计算并发症严重指数(复杂病例与无并发症病例住院时间的比值),采用多因素logistic回归计算预测MAE率,比较各中心及中心量五分位间的观察MAE率、预测MAE率和并发症严重指数。
主要发现
- 观察MAE率范围为0%-39%。
- 预测MAE率范围为21%-29%。
- 观察MAE率与并发症严重程度呈负相关,即某些中心MAE数量较多但并发症严重程度较低。
- MAE的多因素预测因素包括腹主动脉瘤直径>6 cm(OR 2.1,95%CI 2.0-2.3)、女性(OR 2.0,95%CI 1.8-2.2)、慢性肾功能不全(OR 1.9,95%CI 1.7-2.1)、年龄>75岁(OR 1.9,95%CI 1.8-2.1)、充血性心力衰竭(OR 1.7,95%CI 1.5-1.9)、慢性阻塞性肺疾病(OR 1.5,95%CI 1.4-1.6)、糖尿病(OR 1.4,95%CI 1.1-1.7)、负荷试验阳性(OR 1.2,95%CI 1.1-1.4)、术前β受体阻滞剂(OR 1.2,95%CI 1.1-1.3)及术前未使用他汀(OR 1.2,95%CI 1.1-1.3)。
临床怎么用
- 在评估择期EVAR质量时,除MAE率外应同时考虑并发症严重程度,避免仅凭MAE率排名中心。
- 对具有高危因素(如AAA直径>6 cm、女性、肾功能不全、年龄>75岁等)的患者应加强围手术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Major adverse event (MAE) rates are used as an outcome measure after surgical procedures. Although MAE rates summarize the occurrences of adverse events, they do not reflect differences in severity of these events. We propose that a measure of complication severity could provide a more accurate assessment about the quality of care. We aimed to analyze and to describe the regional variation in elective endovascular aneurysm repair (EVAR) MAE rates across centers in the Vascular Study Group of New England and to create an index for describing complication severity. METHODS: Patients undergoing elective EVAR (n = 4731) at 30 Vascular Study Group of New England centers between 2003 and 2016 were studied. The MAE composite end point was defined as the occurrence of any of the following postoperative events: myocardial infarction, dysrhythmia, congestive heart failure, leg ischemia, renal insufficiency, bowel complication, reoperation, surgical site infection, stroke, respiratory complication, and no home discharge. An adjustment factor (complication severity index) was calculated as a ratio of length of stay for complicated to uncomplicated cases. Multivariate logistic regression was used to calculate predicted MAE rates. The observed and predicted MAE rates as well as complication severity index rates were compared among centers and across quintiles of center volume. RESULTS: Observed MAE rates varied widely, ranging from 0% to 39%. Multivariate predictors of MAE included abdominal aortic aneurysm diameter >6 cm (odds ratio [OR], 2.1; 95% confidence interval [CI], 2.0-2.3), female sex (OR, 2.0; 95% CI, 1.8-2.2), chronic renal insufficiency (OR, 1.9; 95% CI, 1.7-2.1), age >75 years (OR, 1.9; 95% CI, 1.8-2.1), congestive heart failure (OR, 1.7; 95% CI, 1.5-1.9), chronic obstructive pulmonary disease (OR, 1.5; 95% CI, 1.4-1.6), diabetes (OR, 1.4; 95% CI, 1.1-1.7), positive stress test result (OR, 1.2; 95% CI, 1.1-1.4), preoperative beta blocker (OR, 1.2; 95% CI, 1.1-1.3), and no preoperative statin (OR, 1.2; 95% CI, 1.1-1.3). Predicted MAE rates had little variation (range, 21%-29%). In comparing observed MAE rates and complication severity, there was an inverse relation between the two, suggesting that although certain centers had a greater number of MAEs, the complications were less severe. CONCLUSIONS: MAE rates after elective EVAR vary widely. However, centers with higher MAE rates tended to have less severe complications, suggesting that observed MAE rates may not be a good measure of outcomes assessment after elective EVARs.
引用
- Noori VJ, Healey CT, Eldrup-Jorgensen J, et al. Comparison of major adverse event rates after elective endovascular aneurysm repair in New England using a novel measure of complication severity. J Vasc Surg. 2018. PMID: 30598356. doi:10.1016/j.jvs.2018.10.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。